Liquidia Reaches Settlement With United Therapeutics; Stock Rises Over 30%
ModernLife Liquidia's shares surged more than 30% on Wednesday, the largest intraday gain since December 2023. The rally followed an agreement to settle all pending lawsuits with United Therapeutics. BTIG responded by upgrading the stock, citing positive developments from the resolution. The settlement removes a significant legal overhang for Liquidia and is expected to allow the company to focus on its business operations without ongoing litigation distractions. Analysts at BTIG believe this development could lead to improved investor confidence in the firm's future prospects.
Topics: analyst upgrade lawsuit resolution price rally
Read the full article at Seeking Alpha
Part of the story Liquidia Shares Rise Over 42% Following Settlement with United Therapeutics (3 articles)